iStent inject® W is designed to create a bypass through the trabecular meshwork and safely lower intraocular pressure. With more than eight years of published efficacy and safety data for iStent inject®, and five years of published efficacy and safety data from iStent inject®, clinical studies show that most patients experience a reduction in reliance on topical glaucoma medications.